Business Description
Radiopharm Theranostics Ltd
ISIN : AU0000181851
Share Class Description:
ASX:RAD: Ordinary SharesDescription
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.39 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -3.29 | |||||
| Beneish M-Score | -4.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.75 | |||||
| 9-Day RSI | 58.75 | |||||
| 14-Day RSI | 56.27 | |||||
| 6-1 Month Momentum % | -21.62 | |||||
| 12-1 Month Momentum % | -68.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | |||||
| Quick Ratio | 1.3 | |||||
| Cash Ratio | 1.06 | |||||
| Days Sales Outstanding | 554.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -39.92 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -12247.83 | |||||
| Net Margin % | -16036.45 | |||||
| FCF Margin % | -7684.28 | |||||
| ROE % | -148.69 | |||||
| ROA % | -68.41 | |||||
| ROIC % | -60.05 | |||||
| ROC (Joel Greenblatt) % | -73383.42 | |||||
| ROCE % | -85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 30 | |||||
| PB Ratio | 0.49 | |||||
| EV-to-EBIT | -0.99 | |||||
| EV-to-Forward-EBIT | -0.73 | |||||
| EV-to-EBITDA | -1.06 | |||||
| EV-to-Forward-EBITDA | -0.74 | |||||
| EV-to-Revenue | 156.11 | |||||
| EV-to-FCF | -2.22 | |||||
| Earnings Yield (Greenblatt) % | -101.32 | |||||
| FCF Yield % | -34.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Radiopharm Theranostics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.299 | ||
| EPS (TTM) (A$) | -0.124 | ||
| Beta | 1.01 | ||
| Volatility % | 51.92 | ||
| 14-Day RSI | 56.27 | ||
| 14-Day ATR (A$) | 0.003371 | ||
| 20-Day SMA (A$) | 0.0255 | ||
| 12-1 Month Momentum % | -68.48 | ||
| 52-Week Range (A$) | 0.021 - 0.095 | ||
| Shares Outstanding (Mil) | 2,200.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Radiopharm Theranostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Radiopharm Theranostics Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Radiopharm Theranostics Ltd Frequently Asked Questions
What is Radiopharm Theranostics Ltd(ASX:RAD)'s stock price today?
The current price of ASX:RAD is A$0.03. The 52 week high of ASX:RAD is A$0.10 and 52 week low is A$0.02.
When is next earnings date of Radiopharm Theranostics Ltd(ASX:RAD)?
The next earnings date of Radiopharm Theranostics Ltd(ASX:RAD) is .
Does Radiopharm Theranostics Ltd(ASX:RAD) pay dividends? If so, how much?
Radiopharm Theranostics Ltd(ASX:RAD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers